This is an archived article that was published on sltrib.com in 2004, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

BRUSSELS, Belgium - ''It's a dream,'' proclaimed the beaming 32-year-old new mother Friday as she cuddled her day-old baby girl, born following a pioneering ovarian tissue transplant performed after the woman was made infertile by chemotherapy.

Doctors hailed the breakthrough procedure, saying it sent a ''big message of hope'' to cancer patients who have lost their fertility and could one day allow women to delay motherhood beyond menopause.

''I am very happy. It's what I always wanted,'' said Ouarda Touirat, who presented her healthy 8-pound, 3-ounce baby Tamara, dressed in pink, at a news conference at Brussels' Cliniques Universitaires Saint-Luc hospital, where she was born Thursday night.

''I was crying at first. It's a dream ... a big miracle,'' said Touirat, who became infertile after she underwent chemotherapy due to Hodgkin's lymphoma in 1997, when she was 25. Her beaming husband, Malik Bouanati, stood beside her.

Dr. Jacques Donnez, head of the department of gynecology and andrology at the hospital and who led the procedure, said it gave cancer survivors a second chance at motherhood.

''It is a big message of hope for all women with cancer who have to have chemotherapy,'' he said of the procedure, in which doctors cut out Touirat's ovarian tissue before she had chemotherapy, then froze it in liquid nitrogen. Five years after she was cleared of cancer, the tissue was grafted back onto her fallopian tubes, allowing for a natural pregnancy.

News of the procedure was published in the British medical journal The Lancet on Friday.

Describing Touirat's condition, Donnez said: ''When I proposed the ovarian graft to the patient we had no idea it was working or not, we just . . . [had] experimental studies in animals.''

He said the Belgian research team worked closely with other researchers working on similar procedures in the United States, Sweden and Britain.

Donnez said 146 women were undergoing the same procedure in Belgium, but Touirat was one of the first seven years ago to have her ovarian tissue frozen in the procedure, known as cryopreservation.

Donnez was optimistic the procedure would be made easier in the years ahead thanks to advances, meaning more women could be given the choice of having a baby.